For a hospitalized patient on Lantus (insulin glargine) 16 units and Actrapid (novorapid, insulin aspart) 4-4-4 units with elevated fasting blood glucose, should the Actrapid dose be increased to 6-6-4 units or remain at 4-4-4 units?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Dose Adjustment for Hospitalized Patient with Elevated Fasting Glucose

Increase Actrapid to 6-6-4 Units on Day 3

For this hospitalized patient with fasting glucose of 210 mg/dL after increasing Lantus from 12 to 16 units, you should increase the Actrapid dose to 6-6-4 units to maintain the 50:50 basal-bolus ratio. 1

Rationale for Dose Adjustment

Basal-Bolus Ratio Maintenance

  • Current guidelines recommend basal-bolus insulin with a 50:50 split between basal (Lantus/Optisulin) and bolus (Actrapid/Novorapid) insulin for hospitalized patients requiring insulin therapy 2
  • With Lantus increased to 16 units on night of day 2, the total basal insulin is now 16 units 1
  • To maintain the 50:50 ratio, total bolus insulin should also equal 16 units daily 1
  • Increasing Actrapid from 4-4-4 (12 units total) to 6-6-4 (16 units total) achieves this 50:50 split 1

Hospitalized Patient Dosing Principles

  • For hospitalized patients who are insulin-naive or on low-dose insulin, the recommended total daily dose is 0.3-0.5 units/kg, with half as basal insulin and half as bolus insulin 1
  • The current regimen of Lantus 16 units plus Actrapid 12 units (total 28 units) was already suboptimal with unequal distribution 1
  • The elevated fasting glucose of 210 mg/dL indicates inadequate basal coverage, which you correctly addressed by increasing Lantus 1

Titration Algorithm for Day 3 and Beyond

Basal Insulin Adjustment

  • Continue increasing Lantus by 4 units every 3 days if fasting glucose remains ≥180 mg/dL (as in this case with 210 mg/dL) 1, 3
  • Target fasting glucose of 80-130 mg/dL 1, 3
  • If hypoglycemia occurs, reduce the dose by 10-20% immediately 1

Bolus Insulin Adjustment

  • Adjust Actrapid doses based on pre-meal and 2-hour postprandial glucose readings 3
  • Increase by 1-2 units or 10-15% every 3 days if postprandial glucose remains elevated 3
  • The 6-6-4 distribution allows for differential adjustment if one meal causes greater glucose excursions 3

Critical Monitoring Requirements

  • Check fasting blood glucose daily to guide basal insulin titration 1, 3
  • Monitor pre-meal and 2-hour postprandial glucose to guide bolus insulin adjustments 3
  • Reassess the insulin regimen every 3 days during active titration 1
  • Watch for signs of hypoglycemia and adjust doses immediately if it occurs 1

Common Pitfall to Avoid

Do not leave the Actrapid at 4-4-4 units when increasing basal insulin, as this creates an imbalanced regimen that deviates from the evidence-based 50:50 split and may lead to suboptimal glycemic control 2, 1. The 50:50 ratio is specifically recommended for hospitalized patients requiring basal-bolus therapy 2, 1.

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Inadequate Glycemic Control on Basal Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is a reasonable fixed daily dose of Novolog (insulin aspart) for an adult patient with type 2 diabetes taking 160 units of 70/30 insulin daily, when adding Novolog TID (three times a day) to their regimen?
What is the best approach for controlling hyperglycemia in a patient with type 2 diabetes who missed a dose of Lantus (insulin glargine) and is NPO for a right heart catheterization?
What is a reasonable starting dose of Lantus (insulin glargine) for a patient with an Hemoglobin A1C (HbA1c) of 10 and weighing 186 pounds?
What adjustments should be made to the Lantus (insulin glargine) dose, carb ratio, and correction scale for a 25-year-old male with type 1 diabetes, body mass index (BMI) 21, and elevated fasting blood glucose level of hyperglycemia, currently on 36 units of Lantus daily?
What treatment is indicated for a 25-year-old female diabetic patient with severe hyperglycemia?
What could be causing a pulsating sensation in the perineum area, similar to a pulse feeling?
What is the prophylaxis dosing of Lovenox (enoxaparin) for post-operative cancer patients at high risk for Deep Vein Thrombosis (DVT)?
What is the best course of action for an elderly male patient with a history of hypertension, presenting with intermittent dizziness and disrupted yawning?
For a patient with hypercobalaminemia (elevated B12 levels), who should they be referred to, a gastroenterologist (GI) or a hematologist?
What is the next best step in managing a patient with ADHD and GAD, currently taking Vyvanse (lisdexamfetamine) 40mg, Mirtazapine (mirtazapine) 15mg, and Prozac (fluoxetine) 40mg, with unmanaged ADHD symptoms and mind racing?
What is the relationship between congenital hepatic fibrosis and the development of structural kidney disease, such as autosomal recessive polycystic kidney disease (ARPKD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.